본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy 한재홍
(외과)
한재홍:김현희:김선영, 이은숙, 강한성, 이시연, 정소연, 이은경. Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy JOURNAL OF BREAST CANCER. 2021-12-02; 2021; 24(6):531~541. IF 3.588 (2020)
김현희
(외과)
Risk-based prediction model for selecting eligible population for lung cancer screening among ever smokers in Korea 김열
(가정의학과)
김열, Seung Hun Jang:박보영:이재호, 이나영. Risk-based prediction model for selecting eligible population for lung cancer screening among ever smokers in Korea TRANSLATIONAL LUNG CANCER RESEARCH. 2021-12-01; 2021; 10(12):4390~4402. IF 6.498 (2020)
박보영
Assessment of the fear of COVID-19 and its impact on lung cancer screening participation among the Korean general population 김열
(가정의학과)
김열:Thuy Linh Duong:이나영, 김용현. Assessment of the fear of COVID-19 and its impact on lung cancer screening participation among the Korean general population TRANSLATIONAL LUNG CANCER RESEARCH. 2021-12-01; 2021; 10(12):4403~4413. IF 6.498 (2020)
Thuy Linh Duong
Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies 유병철
(암진단연구과)
유병철, Se-Hoon Lee:박재광, 최범규, 이영주:장은정, 우상명, 이준화, 김경희, 최원영. Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies EPMA JOURNAL. 2021-11-25; 2021; 12:629~645. IF 6.543 (2020)
최범규
(생물의약품생산실)
박재광
(암진단연구과)
O-GlcNAcylation of Sox2 at threonine 258 regulates the self-renewal and early cell fate of embryonic stem cells. 장현철
(치료내성연구과)
장현철:Dong Keon Kim, Jang-Seok Lee:장한솔, 한수지, 김희연, 유혜진. O-GlcNAcylation of Sox2 at threonine 258 regulates the self-renewal and early cell fate of embryonic stem cells. EXPERIMENTAL AND MOLECULAR MEDICINE. 2021-11-24; 2021; 53(11):1759~1768. IF 8.718 (2020)
Dong Keon Kim, Jang-Seok Lee
Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy 조관호
(양성자치료센터)
조관호:이성욱:. Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2021-11-20; 2021; 20:1~7. IF 3.399 (2020)
이성욱
(방사선종양학과)
Integration of rotatable tandem applicator to conventional ovoid applicator toward complete framework of intensity modulated brachytherapy (IMBT) for cervical cancer 임영경
(방사선종양학과)
임영경, Jin Sung Kim:Hojin Kim:. Integration of rotatable tandem applicator to conventional ovoid applicator toward complete framework of intensity modulated brachytherapy (IMBT) for cervical cancer PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2021-11-17; 2021; 91:131~139. IF 2.685 (2020)
Hojin Kim
ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCi 고성호
(암생물학연구부)
고성호:이전수:최영은, 김선신, 한지연. ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021-11-13; 2021; 22(22):12287~. IF 5.924 (2020)
이전수
(암전이연구과)
Regression and pseudoprogression of pediatric optic pathway glioma in patients treated with proton beam therapy 김주영
(방사선의학연구과)
김주영:윤상희:김학수, 이상현. Regression and pseudoprogression of pediatric optic pathway glioma in patients treated with proton beam therapy PEDIATRIC BLOOD & CANCER. 2021-11-12; 2021; Online:Published. IF 3.167 (2020)
윤상희
(양성자치료센터)
TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma 유혜진
(암미세환경연구과)
유혜진:이은영:최범규, 김대홍. TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma MOLECULES AND CELLS. 2021-11-12; 2021; 44(11):784~794. IF 5.034 (2020)
이은영
(암미세환경연구과)